Responses
Research paper
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 13 April 2016
- Published on: 13 April 2016MS may be a progressive disease occurring independently of exacerbations and remissions.Show More
I read the article on disability progression in patients with multiple sclerosis whether treated with interferon or not with interest(1)
Although may of the placebo treated patients probably were treated with some form of immunomodulatory treatment after the study period, it certainly raises the question of whether neuronal progression in multiple sclerosis is due to accumulated deficits from exacerbations and re...
Conflict of Interest:
None declared.